Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1393)
908 Devices Inc. (MASS)
Knopp Kevin J. — Director
Shares
222
Price
$9.07
Total Value
$2.01K
Shares Held After
732,603
% of Holdings
0.0%
BICYCLE THERAPEUTICS PLC (BCYC)
Lee Kevin — Director
Shares
5,905
Price
$4.27
Total Value
$25.21K
Shares Held After
605,408
% of Holdings
1.0%
BICYCLE THERAPEUTICS PLC (BCYC)
Thompson Travis Alvin — Chief Financial Officer
Shares
819
Price
$4.27
Total Value
$3.50K
Shares Held After
64,545
% of Holdings
1.3%
HEALTHEQUITY, INC. (HQY)
Fiore Michael Henry — EVP, CHIEF COMMERCIAL OFFICER
Shares
2,470
Price
$95.00
Total Value
$234.65K
Shares Held After
56,643
% of Holdings
4.2%
BICYCLE THERAPEUTICS PLC (BCYC)
Skynner Michael — CHIEF SCIENTIFIC OFFICER
Shares
1,859
Price
$4.27
Total Value
$7.94K
Shares Held After
157,703
% of Holdings
1.2%
BICYCLE THERAPEUTICS PLC (BCYC)
Perry Jennifer Scott — Chief Operating Officer
Shares
1,036
Price
$4.27
Total Value
$4.42K
Shares Held After
91,428
% of Holdings
1.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Tatsis Ourania — EVP, Chief Reg. & Quality Off.
Shares
1,500
Price
$524.99
Total Value
$787.49K
Shares Held After
45,321
% of Holdings
3.2%
Privia Health Group, Inc. (PRVA)
Morris Matthew Shawn — Director
Shares
59,037
Price
$27.33
Total Value
$1.61M
Shares Held After
76,651
% of Holdings
43.5%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
200
Price
$650.15
Total Value
$130.03K
Shares Held After
17,303
% of Holdings
1.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
McKechnie Duncan — EVP, Chief Commercial Officer
Shares
1,541
Price
$519.00
Total Value
$799.78K
Shares Held After
11,001
% of Holdings
12.3%
Privia Health Group, Inc. (PRVA)
Mountcastle David — EVP & Chief Financial Officer
Shares
24,734
Price
$27.50
Total Value
$680.18K
Shares Held After
186,728
% of Holdings
11.7%
Butterfly Network, Inc. (BFLY)
Carlson Megan — CAO and SVP, Finance
Shares
41,303
Price
$7.96
Total Value
$328.94K
Shares Held After
465,906
% of Holdings
8.1%
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
HRT FINANCIAL LP — 10% Owner
Shares
7,851
Price
$3.54
Total Value
$27.79K
Shares Held After
90,407
% of Holdings
8.7%
Crinetics Pharmaceuticals, Inc. (CRNX)
Vivaldi Coelho Rogerio — Director
Shares
3,000
Price
$40.00
Total Value
$120.00K
Shares Held After
19,225
% of Holdings
13.5%
ANI PHARMACEUTICALS INC (ANIP)
CAREY STEPHEN P. — SVP & CFO
Shares
3,313
Price
$86.00
Total Value
$284.92K
Shares Held After
177,543
% of Holdings
1.8%
ImmunityBio, Inc. (IBRX)
Cohen Cheryl — Director
Shares
131,210
Price
$9.50
Total Value
$1.25M
Shares Held After
125,386
% of Holdings
51.1%
Sight Sciences, Inc. (SGHT)
Rodberg James — Chief Financial Officer
Shares
6,902
Price
$5.36
Total Value
$36.99K
Shares Held After
224,037
% of Holdings
3.0%
Sight Sciences, Inc. (SGHT)
Bauerlein Alison — Chief Operating Officer
Shares
24,184
Price
$5.36
Total Value
$129.63K
Shares Held After
664,709
% of Holdings
3.5%
PALISADE BIO, INC. (PALI)
Baltera Robert Jr. — Director
Shares
10,000
Price
$1.98
Total Value
$19.80K
Shares Held After
366,904
% of Holdings
2.7%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
44,838
Price
$22.59
Total Value
$1.01M
Shares Held After
230,713
% of Holdings
16.3%
iRhythm Holdings, Inc. (IRTC)
Freeman Sean Clinton — EVP, Strategy & Corp Devt
Shares
918
Price
$124.71
Total Value
$114.48K
Shares Held After
13,641
% of Holdings
6.3%
iRhythm Holdings, Inc. (IRTC)
Turakhia Minang — CHIEF MED/SCI OFCR EVP ADVTECH
Shares
1,423
Price
$124.71
Total Value
$177.46K
Shares Held After
53,620
% of Holdings
2.6%
Teladoc Health, Inc. (TDOC)
Catapano Joseph Ronald — Chief Accounting Officer
Shares
653
Price
$9.10
Total Value
$5.94K
Shares Held After
12,267
% of Holdings
5.1%
Immunovant, Inc. (IMVT)
Venker Eric — Director
Shares
3,092
Price
$38.48
Total Value
$118.98K
Shares Held After
254,280
% of Holdings
1.2%
SI-BONE, Inc. (SIBN)
Maheshwari Anshul — Chief Financial Officer
Shares
1,560
Price
$16.73
Total Value
$26.11K
Shares Held After
256,560
% of Holdings
0.6%
SI-BONE, Inc. (SIBN)
Maheshwari Anshul — Chief Financial Officer
Shares
1,757
Price
$16.80
Total Value
$29.52K
Shares Held After
258,120
% of Holdings
0.7%
Intellia Therapeutics, Inc. (NTLA)
Dulac Edward J III — EVP, Chief Financial Officer
Shares
4,677
Price
$18.00
Total Value
$84.19K
Shares Held After
156,286
% of Holdings
2.9%
SI-BONE, Inc. (SIBN)
PISETSKY MICHAEL A. — SVP, Ops & Adm/Chief Legal Ofr
Shares
1,301
Price
$16.73
Total Value
$21.76K
Shares Held After
277,375
% of Holdings
0.5%
SI-BONE, Inc. (SIBN)
PISETSKY MICHAEL A. — SVP, Ops & Adm/Chief Legal Ofr
Shares
34
Price
$16.86
Total Value
$573.24
Shares Held After
278,676
% of Holdings
0.0%
SI-BONE, Inc. (SIBN)
PISETSKY MICHAEL A. — SVP, Ops & Adm/Chief Legal Ofr
Shares
1,799
Price
$16.70
Total Value
$30.04K
Shares Held After
278,710
% of Holdings
0.6%
REGENXBIO Inc. (RGNX)
PAKOLA STEVE — Chief Medical Officer
Shares
2,161
Price
$13.64
Total Value
$29.48K
Shares Held After
213,009
% of Holdings
1.0%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
17,873
Price
$13.00
Total Value
$232.40K
Shares Held After
90,180
% of Holdings
16.5%
LABCORP HOLDINGS INC. (LH)
Vaughn Bryan T — EVP and President, Diagnostics
Shares
234
Price
$286.19
Total Value
$66.97K
Shares Held After
6,746
% of Holdings
3.4%
LABCORP HOLDINGS INC. (LH)
Kyle Kathryn W — EVP, Chief Legal Officer
Shares
92
Price
$286.19
Total Value
$26.33K
Shares Held After
3,904
% of Holdings
2.3%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
24,335
Price
$23.33
Total Value
$567.74K
Shares Held After
208,504
% of Holdings
10.5%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
75,665
Price
$22.35
Total Value
$1.69M
Shares Held After
232,839
% of Holdings
24.5%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
9,821
Price
$2.49
Total Value
$24.45K
Shares Held After
2,641,308
% of Holdings
0.4%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
147
Price
$1.55
Total Value
$227.85
Shares Held After
73,135
% of Holdings
0.2%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
1,460
Price
$1.55
Total Value
$2.26K
Shares Held After
724,395
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
225
Price
$556.36
Total Value
$125.18K
Shares Held After
45,172
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
990
Price
$555.83
Total Value
$550.27K
Shares Held After
45,397
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
299
Price
$554.45
Total Value
$165.78K
Shares Held After
46,387
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
2,201
Price
$553.52
Total Value
$1.22M
Shares Held After
46,686
% of Holdings
4.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,818
Price
$552.61
Total Value
$1.00M
Shares Held After
48,887
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,467
Price
$551.30
Total Value
$808.75K
Shares Held After
50,705
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
384
Price
$550.02
Total Value
$211.21K
Shares Held After
52,172
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
258
Price
$548.73
Total Value
$141.57K
Shares Held After
52,556
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
658
Price
$548.00
Total Value
$360.58K
Shares Held After
52,814
% of Holdings
1.2%
Neurogene Inc. (NGNE)
Cvijic Christine Mikail — Director
Shares
1,530
Price
$35.23
Total Value
$53.90K
Shares Held After
88,840
% of Holdings
1.7%
Neurogene Inc. (NGNE)
Cvijic Christine Mikail — Director
Shares
2,531
Price
$34.58
Total Value
$87.52K
Shares Held After
90,370
% of Holdings
2.7%
Showing 1–50 of 1393 transactions (page 1 of 28)